Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Role of the lncRNA complex HCP5 in glioma treatment

Nitrogen dioxide reduction leads to an increase in crop yield

Olfactory Implants on the rise to fix the dysfunctional system

Role of the lncRNA complex HCP5 in glioma treatment
  • BiotechToday
  • World

Role of the lncRNA complex HCP5 in glioma treatment

bioxone July 7, 2022July 7, 2022

Harini Balasubramanian, Anna University, Chennai

The investigation of non-coding regions of the DNA, especially miRNA and long non-coding RNA (lncRNA), and their role in various disease phenotypes, has drawn the attention of scientists in recent years. Gliomas are neoplasias usually found in the brain, a stage IV progression of which leads to glioblastoma (GBM). GBM is highly fatal with a median survival rate of merely 15 months. It is therefore essential that for a better understanding of the disease progression, more studies need to be conducted.

LncRNAs have been found to interact with miRNAs — short non-coding RNAs with up to 22 nucleotides. miRNAs regulate most of the post-transcriptional gene expression in a cell – to either stimulate malignancy or tumor suppression. lncRNA HLA complex P5 (HCP5) has been discovered to have carcinogenic properties by promoting cell proliferation, migration, and angiogenesis in follicular thyroid carcinoma cells. miR-205 is a miRNA of interest in this study, given its tumor-suppressive properties in gliomas, as established in previous studies.

So, this study investigated the previously unexplored role of HCP5 in glioma progression. Also, it further investigated the interaction of HCP5 with miR-205 and their combined molecular mechanisms along the VEGF-A axis (an essential factor in vascularizing tumors) in affecting glioma progression. 

Methodology:

  1. RNA Sequencing, Data processing, Analysis
  2. The culture of a patient’s primary GBM cell line (U251), Normal Human Astrocyte (NHA), and tumor tissue were obtained from patient.
  3. Cell transfection: siRNA against HCP5, miR-205 mimics, and negative control mimics were synthesized. Vectors for shRNA targeting HCP5 and the human VEGF-A gene were transfected into primary GBM cells.
  4. Cell viability assay, scratch wound healing assay for cell migration and invasiveness, and cell proliferation assays were conducted.
  5. In vivo xenograft study in mice was performed by injecting them subcutaneously with U251 cells post-transfection.
  6. qRT-PCR was performed to quantify expression levels of HCP5, miR-205, and VEGF-A.
  7. Western Blot analysis was done to primarily quantify VEGF-A protein concentration.

Outcome & Inference:

In different types of cancers, HCP5 was found to be significantly more upregulated compared to healthy control samples. The RNA sequencing data derived from TCGA projects also revealed the prognosis and thereby, that the survival rate had a negative correlation with expression levels 0f HCP5. For gliomas, in particular, the results showed that overexpression of HCP5 may be implicated in glioma progression.

Conversely, it also proved that in cells with siRNA transfection and subsequent HCP5 knockdown, its downregulation prominently mitigated cell viability and migration. In vivo studies also showed slowed tumor growth in mice injected with HCP5-silenced GBM cells.

In addition, HCP5’s interaction with miR-205 downregulated (relative to NHA cell line) the former’s expression in GBM cell lines. It was also found that miR-205 expression has an inverse relationship with HCP5, as the latter-silenced GBM cells had elevated levels of miR-205.

Regarding the feedback loop modulating GBM progression, the researchers determined that HCP5 downregulation was strongly associated with the downregulation of VEGF-A, both of which strikingly decreased upon upregulation of miR-205. So, they ascertained that by targeting miR-205, HCP5 modulated the expression of VEGF-A.

The results of this study, therefore, provide potential theragnostic targets for glioma treatment and specific drug development.

Reference:

Cheng, R., Ji, L., Su, H., Wang, L., Jia, D., Yao, X. and Ji, H. Silencing of Long Noncoding RNA HLA Complex P5 (HCP5) Suppresses Glioma Progression through the HCP5-miR-205-Vascular Endothelial Growth Factor A Feedback Loop. BioMed Research International, 2022. https://pubmed.ncbi.nlm.nih.gov/35769676/

Also read: Nitrogen dioxide reduction leads to an increase in crop yield

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged feedback mechanism Glioma glioma treatment HCP5 lncRNA lncRNA complex miRNA transcriptomics Prognosis vascularization

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Olfactory Implants on the rise to fix the dysfunctional system

BioTech Today July 9, 2022

Jaladhi Shah, Dr D. Y. Patil Biotechnology and Bioinformatics Institute, Pune The aftermath of COVID-19 on the olfactory system: Following the multiple waves of COVID-19 that the world has witnessed, a lot of people, infected or uninfected have been subject to making changes in their lives. One such lifestyle adjustment that a lot of COVID-19 […]

Olfactory Implants

Related Post

  • BiotechToday
  • World

DRH: DNA repair hotspots in neurons and Age-related disorders

bioxone April 23, 2021April 23, 2021

Sayak Banerjee, Amity University Kolkata Many people have a wrong conception that since DNA damage can occur any time at any genomic site of a neuron, DNA repairs take place throughout the genome arbitrarily. Salk scientists have proved this view to be invalid saying that genomic sites are benefitted. Genomic sites are also known as […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Pfizer vaccine- Is it really effective?

bioxone March 26, 2021March 26, 2021

Thota Kanishka Rao, Amity University Kolkata Coronavirus became a household name, as the pandemic swept people off their feet, locking them in their houses, rendering them sick, leading to death on severe occasions. After months into the pandemic, in December 2020, the government of Israel approved the BNT162b2 COVID-19 vaccination and proclaimed a mass immunization […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • World

GENOMIC ANALYSIS OF SALIVARY DUCT CARCINOMA

bioxone September 18, 2020September 18, 2020

–Subhangi Das , Bankura Sammilani College Salivary duct carcinoma (SDC) is one of the rarest incursive subtypes of salivary gland cancer that microscopically resembles high-grade ductal carcinoma of the breast, with both in situ and invasive pattern. Ordinary chemotherapy and radiation have just restricted viability for the metastatic SDC2, thus treatment is needed against this […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy